Skip to main content
. Author manuscript; available in PMC: 2010 Jun 12.
Published in final edited form as: Vaccine. 2009 May 9;27(29):3811–3820. doi: 10.1016/j.vaccine.2009.04.054

Fig. 6.

Fig. 6

Fluzone®-specific cytokine production by rhesus monkey T cells is increased after 22.5μg (high dose) JVRS-100-adjuvanted Fluzone® vaccination compared to Fluzone® alone. PBMCs were restimulated in vitro and intracellularly stained for IL-2, IFN-γ and TNF-α producing CD4+ and CD8+ T cells. The T cell populations were evaluated by flow cytometric analysis. *P<0.05; **P<0.01.